Skip to main content
Figure 10 | BMC Cancer

Figure 10

From: Parallel screening of FDA-approved antineoplastic drugs for identifying sensitizers of TRAIL-induced apoptosis in cancer cells

Figure 10

Comparison between different treatment methodologies in PC3-TR cells. (a) Mitoxantrone (b) and mithramycin in PC3-TR prostate cancer cells. Single-agent treatments are shown as "dark grey diamonds", sequential combination treatments with 10 ng/mL of TRAIL are shown as "light grey squares" and simultaneous combination treatments with 10 ng/mL of TRAIL are shown as "grey triangles". Data are presented on a logarithmic scale and the lines connecting data points are for visualization only.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us